Eleva and 3PBIOVIAN sign strategic GMP manufacturing and technology alliance to boost capacity for Eleva’s platform and pipelineFebruary 4, 2025Read more >
3PBIOVIAN strengthens its Leadership team with the appointment of a Business Development Director for Advanced TherapiesOctober 9, 2024Read more >
3PBIOVIAN receives the Talent Acceleration Award at the 2024 BWB Awards in BostonSeptember 25, 2024Read more >
3PBIOVIAN strengthens its executive team with the appointment of three new directorsSeptember 19, 2024Read more >
Rokote Laboratories signs an agreement with 3PBIOVIAN for GMP manufacturing of adenovirus vector-based COVID-19 vaccineAugust 29, 2024Read more >
Biovian and 3P Biopharmaceuticals join forces to create 3PBIOVIAN, a leading pan-European biologics CDMOFebruary 1, 2024Read more >
3P Biopharmaceuticals: building a legacy of innovation and excellence in biotechnologyDecember 20, 2023Read more >
Biovian announces the successful refinancing of its existing debt package and the securing of new funding to support GeneCity facility expansion December 18, 2023Read more >
3P Biopharmaceuticals and the University of Navarra bring the Neanderthal world and biomedicine to the public in a successful event.October 19, 2023Read more >